Cancer has been around for a very long time. This disease has destroyed the lives of millions of people across the globe. The fight against cancer seems to be a never ending process, but there is hope. This hope comes in the form of targeted cancer therapies. Anti-body Drug Conjugates are the name and saving lives is the game. This is one of the 21st century’s most coveted cancer fighting medications thanks to the great results it’s yielding. These powerful medications are produced by biotech company Seattle Genetics, and this company is making an impact on a worldwide scale. Seattle Genetics has been around since 1998, and it has grown into a cancer research powerhouse.
Dr. Clay Siegall is the CEO here, and he uses his broad educational background to run this huge organization. This guy has decades under his belt since he began his successful career in biomedical studies. The National Institute of Health and Bristol Myers Squibb are just two of the prominent companies that he has worked with throughout the years. Dr. Siegal has many different titles such as being a scientist, a doctor, a guest speaker and an entrepreneur. There isn’t anything this guy can’t do, especially when it comes to fighting cancer. He has the fortitude, the passion and the ability to save lives. The dramatic growth of Seattle Genetics is a reflection of what he has brought to the table. There is no more time for guessing, especially when lives are at risk.
By securing strategic multiple licensing with companies such as GlaxoSmithKline, AbbVie and Pfzer, Seattle Genetics have been able to distribute its powerful medications worldwide. In 2011, these medications secured FDA approval and the rest is history. Over 65 countries around the globe are supplying the medications to cancer stricken patients. These medications just happens to yield much better results than other medications of the past. Cancer research has come a long way and Dr. Clay Siegall is steering this huge ship to even more success.